SAFE AND EFFECTIVE MEDICINES FOR CHILDREN Impresión bajo demanda

SAFE AND EFFECTIVE MEDICINES FOR CHILDREN

Código de artículo:
4396079698
ISBN:
9780309225496
Páginas:
432
Tipo de libro:
Impresión bajo demanda

Impresión Bajo Demanda.


Tiempo de despacho de pedidos es de 15 a 20 días hábiles, una vez confirmado el pago del pedido. 

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.

Artículos relacionados